Zobrazeno 1 - 10
of 39
pro vyhledávání: '"Atul Padole"'
Autor:
Ramandeep Singh, Mannudeep K Kalra, Chayanin Nitiwarangkul, John A Patti, Fatemeh Homayounieh, Atul Padole, Pooja Rao, Preetham Putha, Victorine V Muse, Amita Sharma, Subba R Digumarthy
Publikováno v:
PLoS ONE, Vol 13, Iss 10, p e0204155 (2018)
BACKGROUND:Deep learning (DL) based solutions have been proposed for interpretation of several imaging modalities including radiography, CT, and MR. For chest radiographs, DL algorithms have found success in the evaluation of abnormalities such as lu
Externí odkaz:
https://doaj.org/article/d062da2c436d49b68af1771ed751fb0a
Autor:
Subba R. Digumarthy, Ibiayi Dagogo-Jack, Mannudeep K. Kalra, Ramandeep Singh, Eric W. Zhang, Dexter P. Mendoza, Atul Padole
Publikováno v:
Translational Lung Cancer Research. 9:1441-1451
Background The clinical features and traditional semantic imaging characteristics of BRAF-mutated non-small cell lung cancer (NSCLC) have been previously reported. The radiomic features of BRAF-mutated NSCLC and their role in predicting cancer stage,
Autor:
Sjirk J. Westra, Mannudeep K. Kalra, Ruth P. Lim, Katherine Nimkin, Michael S. Gee, Madan M. Rehani, Pallavi Sagar, Atul Padole
Publikováno v:
Insights into Imaging, Vol 10, Iss 1, Pp 1-11 (2019)
Insights into Imaging
Insights into Imaging
Objective To develop and assess the value and limitations of an image quality scoring criteria (IQSC) for pediatric CT exams. Methods IQSC was developed for subjective assessment of image quality using the scoring scale from 0 to 4, with 0 indicating
Autor:
Atul Padole, Chayanin Nitiwarangkul, Ge Wang, Uwe Kruger, Ruhani Doda Khera, Hongming Shan, Mannudeep K. Kalra, Fatemeh Homayounieh
Publikováno v:
Nat Mach Intell
Commercial iterative reconstruction techniques help to reduce CT radiation dose but altered image appearance and artifacts limit their adoptability and potential use. Deep learning has been investigated for low-dose CT (LDCT). Here we design a modula
Autor:
Atul, Padole, Ramandeep, Singh, Eric W, Zhang, Dexter P, Mendoza, Ibiayi, Dagogo-Jack, Mannudeep K, Kalra, Subba R, Digumarthy
Publikováno v:
Transl Lung Cancer Res
BACKGROUND: The clinical features and traditional semantic imaging characteristics of BRAF-mutated non-small cell lung cancer (NSCLC) have been previously reported. The radiomic features of BRAF-mutated NSCLC and their role in predicting cancer stage
Autor:
Zofia Piotrowska, Dexter P. Mendoza, Atul Padole, Subba R. Digumarthy, P Gabriel Peterson, Tianqi Chen, Lecia V. Sequist
Publikováno v:
Cancers, Vol 11, Iss 9, p 1360 (2019)
Cancers
Volume 11
Issue 9
Cancers
Volume 11
Issue 9
Diffuse lung metastases have been reported in non-small cell lung cancer (NSCLC) harboring epidermal growth factor receptor (EGFR) mutations. The purpose of our study was to compare the incidence of diffuse lung metastases in EGFR-mutant NSCLC and EG
Autor:
Subba R, Digumarthy, Dexter P, Mendoza, Atul, Padole, Tianqi, Chen, P Gabriel, Peterson, Zofia, Piotrowska, Lecia V, Sequist
Publikováno v:
Cancers
Diffuse lung metastases have been reported in non-small cell lung cancer (NSCLC) harboring epidermal growth factor receptor (EGFR) mutations. The purpose of our study was to compare the incidence of diffuse lung metastases in EGFR-mutant NSCLC and EG
Predicting malignant potential of subsolid nodules: can radiomics preempt longitudinal follow up CT?
Autor:
Subba R. Digumarthy, Atul Padole, Shivam Rastogi, Melissa C. Price, Mannudeep K. Kalra, Lecia V. Sequist, Meghan J. Mooradian
Publikováno v:
Cancer Imaging
Cancer Imaging, Vol 19, Iss 1, Pp 1-8 (2019)
Cancer Imaging, Vol 19, Iss 1, Pp 1-8 (2019)
Background To assess if radiomics can differentiate benign and malignant subsolid lung nodules (SSNs) on baseline or follow up chest CT examinations. If radiomics can differentiate between benign and malignant subsolid lung nodules, the clinical impl
Publikováno v:
Medicine
To assess the role of radiomic features in distinguishing squamous and adenocarcinoma subtypes of nonsmall cell lung cancers (NSCLC) and predict EGFR mutations. Institution Review Board-approved study included chest CT scans of 93 consecutive patient
Autor:
Tianqi Chen, Alice T. Shaw, Jo-Anne O. Shepard, Subba R. Digumarthy, Dexter P. Mendoza, Ibiayi Dagogo-Jack, Atul Padole
Publikováno v:
Lung cancer (Amsterdam, Netherlands). 129
Objectives Mutations in the BRAF gene have emerged as a validated molecular target in the treatment of non-small cell lung cancer (NSCLC). These mutations can be classified into three functional classes based on their mechanisms of oncogenesis. The r